Showing results (181-190 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|June 1, 1995
The phencyclidine-glutamate model of schizophreniaA L HalberstadtClinical Neuropharmacology|June 1, 1995
Trauma, axonal injury, and amyotrophic lateral sclerosis: a clinical correlate of a neuropharmacologic modelJ E RiggsClinical Neuropharmacology|April 1, 1996
Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndromeM Demirkiran, J Jankovic, J M DeanClinical Neuropharmacology|June 1, 1993
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystoniaA S Buchman, C L Comella, G T Stebbins, et al.Clinical Neuropharmacology|December 9, 1998
Hypothermia induced by atypical neurolepticsM Schwaninger, M Weisbrod, S Schwab, et al.Clinical Neuropharmacology|December 9, 1998
A six-month study of pergolide and levodopa in de novo Parkinson's disease patientsJ Kulisevsky, D López-Villegas, C García-Sánchez, et al.Clinical Neuropharmacology|October 28, 1998
Symptomatic and prophylactic treatment of migraine: a critical reappraisalD Deleu, Y Hanssens, E A WorthingClinical Neuropharmacology|October 28, 1998
Droperidol in the interim management of severe mania: case reports and literature reviewE S Brown, S C Dilsaver, T C Bowers, et al.Clinical Neuropharmacology|October 1, 1996
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegilineJ Dingemanse, J Kneer, A Wallnöfer, et al.Clinical Neuropharmacology|October 1, 1996
D-cycloserine adjuvant therapy to molindone in the treatment of schizophreniaR B Rosse, M Fay-McCarthy, K Kendrick, et al.Pageof 236